Similar articles

• Immunosuppressive therapy in chronic liver disease.

  Sherlock S. Sherlock S. Minerva Med. 1978 Aug 18;69(38):2605-9. Minerva Med. 1978. PMID: 714260 Clinical Trial.
• [Indications, method and effectiveness of immunosuppressive treatment in chronic active hepatopathies. I. Changes in the general dynamics of the disease. II. Slowing-down of the chronicization process].

  Nicolaescu T, Stoiculescu P, Bittman E, Bordeianu A, Gheorghe N, Pintilescu V, Metz L. Nicolaescu T, et al. Med Interna (Bucur). 1974 Apr;26(4):453-64. Med Interna (Bucur). 1974. PMID: 4839352 Romanian. No abstract available.
• [Immunoglobulins and histological findings in chronic liver diseases treated with immunosuppressive agents].

  Bauch K, Büttner W, Lewicki I, Zimmermann S, Dempe A. Bauch K, et al. Z Gesamte Inn Med. 1973 Jun 1;28(11):Suppl:169-72. Z Gesamte Inn Med. 1973. PMID: 4728086 German. No abstract available.
• [Immunodepressants in chronic liver diseases (a review of the literature and the authors' own data)].

  Podymova SD, Nasonov EL. Podymova SD, et al. Ter Arkh. 1976;48(3):40-8. Ter Arkh. 1976. PMID: 795076 Review. Russian. No abstract available.
• [Glucocorticoids and immunosuppressive agents in liver diseases].

  Arpa Gutierrez FJ, Silva Pozo J. Arpa Gutierrez FJ, et al. Rev Esp Enferm Apar Dig. 1970 Dec 1;32(7):763-82. Rev Esp Enferm Apar Dig. 1970. PMID: 4926636 Review. Spanish. No abstract available.